Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates
(NASDAQ: MDGL) Delayed: 531.68 -9.4 (1.74%)
Previous Close $541.08    52 Week High $18.24 
Open $534.17    52 Week Low $6.60 
Day High $540.00    P/E N/A 
Day Low $526.67    EPS $0.00 
Volume 76,870